EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 04 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
237-066-7
|
13598-36-2
|
Acute Tox. 4; Skin Corr. 1A |
|||
|
231-633-2
|
7664-38-2
|
Skin Corr. 1B |
|||
|
233-663-1
|
10294-56-1
|
Acute Tox. 4; Skin Corr. 1A |
|||
|
233-060-3
|
10026-13-8
|
Acute Tox. 2; Acute Tox. 4; STOT RE 2; Skin Corr. 1B |
|||
|
215-236-1
|
1314-56-3
|
Skin Corr. 1A |
|||
|
232-178-2
|
7789-60-8
|
Skin Corr. 1B; STOT SE 3 |
|||
|
231-749-3
|
7719-12-2
|
Acute Tox. 2; STOT RE 2; Skin Corr. 1A |
|||
|
233-046-7
|
10025-87-3
|
Acute Tox. 2; STOT RE 1; Acute Tox. 4; Skin Corr. 1A |
|||
|
238-887-3
|
14816-18-3
|
Repr. 2; Acute Tox. 4; Skin Sens. 1 |
|||
|
201-607-5
|
85-44-9
|
Acute Tox. 4; STOT SE 3; Skin Irrit. 2; Eye Dam. 1; Resp. Sens. 1; Skin Sens. 1 |
|||
|
200-332-8
|
57-47-6
|
Acute Tox. 2 |
|||
|
202-128-4
|
92-13-7
|
Acute Tox. 2 |
|||
|
201-462-8
|
83-26-1
|
Acute Tox. 3; STOT RE 1 |
|||
|
203-808-3
|
110-85-0
|
Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
|||
|
203-808-3
|
110-85-0
|
Repr. 2; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
|||
|
205-551-2
|
142-64-3
|
Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
228-042-7
|
6094-40-2
|
Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
217-775-8
|
1951-97-9
|
Repr. 2; Eye Irrit. 2; Skin Irrit. 2; Resp. Sens. 1; Skin Sens. 1 |
|||
|
203-813-0
|
110-89-4
|
Flam. Liq. 2; Acute Tox. 3; Skin Corr. 1B |
|||
|
245-430-1
|
23103-98-2
|
Carc. 2; Acute Tox. 3; Skin Sens. 1 |
|||
|
245-704-0
|
23505-41-1
|
Acute Tox. 3; Acute Tox. 4 |
|||
|
249-528-5
|
29232-93-7
|
Acute Tox. 4; STOT RE 1 |
|||
|
The residue from the distillation of high temperature coal tar. A black solid with an approximate softening point from 30°C to 180°C (86°F to 356°F). Composed primarily of a complex mixture of three or more membered condensed ring aromatic hydrocarbons.
|
266-028-2
|
65996-93-2
|
Carc. 1A; Muta. 1B; Repr. 1B |
yes |
|
|
A complex black solid obtained by the heat treatment of low temperature coal tar pitch. It has a softening point within the approximate range of 50°C to 140°C (122°F to 284°F). Composed primarily of a complex mixture of aromatic compounds.
|
292-653-5
|
90669-58-2
|
Carc. 1B |
||
|
The product obtained by air-blowing, at elevated temperature, low-temperature coal tar pitch. It has a softening-point within the approximate range of 70°C to 180°C (158°F to 356°F). Composed primarily of a complex mixture of hydrocarbons.
|
292-654-0
|
90669-59-3
|
Carc. 1B |
||
|
A complex black solid or semi-solid obtained from the distillation of a low temperature coal tar. It has a softening point within the approximate range of 40°C to 180°C (104°F to 356°F). Composed primarily of a complex mixture of hydrocarbons.
|
292-651-4
|
90669-57-1
|
Carc. 1B |
||
|
The residue from the distillation of a mixture of coal tar and aromatic petroleum streams. A solid with a softening point from 40°C to 180°C (104°F to 356°F). Composed primarily of a complex combination of three or more membered condensed ring aromatic hydrocarbons.
|
269-109-0
|
68187-57-5
|
Carc. 1B |
||
|
263-072-4
|
61789-60-4
|
Carc. 1B |
|||
|
215-648-1
|
1336-36-3
|
STOT RE 2 |
|||
|
231-119-8
|
7440-09-7
|
Water-react. 1; Skin Corr. 1B |
|||
|
246-376-1
|
24634-61-5
|
Eye Irrit. 2 |
|||
|
266-578-3
|
67118-55-2
|
yes |
|||
|
233-002-7
|
10007-85-9
|
Eye Irrit. 2 |
|||
|
232-156-2
|
7789-29-9
|
Acute Tox. 3; Skin Corr. 1B |
|||
|
231-829-8
|
7758-01-2
|
Ox. Sol. 1; Carc. 1B; Acute Tox. 3 |
|||
|
223-289-7
|
3811-04-9
|
Ox. Sol. 1; Acute Tox. 4 |
|||
|
232-140-5
|
7789-00-6
|
Carc. 1B; Muta. 1B; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2; Skin Sens. 1 |
yes |
||
|
209-676-3
|
590-28-3
|
Acute Tox. 4 |
|||
|
231-906-6
|
7778-50-9
|
Ox. Sol. 2; Carc. 1B; Muta. 1B; Repr. 1B; Acute Tox. 2; Acute Tox. 3; STOT RE 1; Acute Tox. 4; Skin Corr. 1B; Resp. Sens. 1; Skin Sens. 1 |
yes |
||
|
213-029-0
|
917-58-8
|
Self-heat. 1; Skin Corr. 1B |
|||
|
232-151-5
|
7789-23-3
|
Acute Tox. 3 |
|||
|
231-594-1
|
7646-93-7
|
Skin Corr. 1B; STOT SE 3 |
|||
|
215-181-3
|
1310-58-3
|
Acute Tox. 4; Skin Corr. 1A |
|||
|
234-329-8
|
11103-86-9
|
yes |
|||
|
212-736-1
|
865-33-8
|
Self-heat. 1; Skin Corr. 1B |
|||
|
231-832-4
|
7758-09-0
|
Ox. Sol. 2; Acute Tox. 3 |
|||
|
231-911-3
|
7778-73-6
|
Carc. 2; Acute Tox. 2; Acute Tox. 3; Eye Irrit. 2; STOT SE 3; Skin Irrit. 2 |
|||
|
231-912-9
|
7778-74-7
|
Ox. Sol. 1; Acute Tox. 4 |
|||
|
223-393-2
|
3871-99-6
|
yes |
|||
|
220-527-1
|
2795-39-3
|
Carc. 2; Repr. 1B; STOT RE 1; Acute Tox. 4; Lact. |
|||